Ode to Glenn
Pacira Corporate Espionage- How could the SEC Fall for Pacira’s Consultants Bullshit claims?
In the winter 2016, the flood of Pacira sales resumes into PixarBio was thought to be a direct result of Pacira’s slow sales of Exparel. Their Global sales leader told me “we have 95% brand recognition yet single digit sales growth, the product is not being accepted by the market”
Year over year sales of Exparel were dropping dramatically, even though they were the only non-opiate drug FDA approved for post-surgical pain during a “war on opiates”. Pacira’s Exparel sales were dropping as the direct result of a product called Exparel that was not removing opiates from the post- surgical pain mgmt. cycle. With a median time to first opiate intake after surgery at just 15 hours. The Pacira salesforce was giving up on Exparel, even though Exparel is the only non-opiate drug that is FDA approved for post-surgical pain
Pacira Targets PixarBio
Pacira’s Sales employees pursued PixarBio aggressively. In a short period of time we hired former Pacira Sales person Glenn Reiser and Taunia Markvicka. On Taunia’s third day with PixarBio, she revealed she had a contract that paid her over $1,000,000 in 2016 to write reports on PixarBio for Pacira Pharmaceutical, while she worked at PixarBio. She told us this after a 3 hour science review of NeuroRelease. Taunia completed her science transfer meetings and drove home to Pacira on her third day of working at PixarBio. A pure theft of corporate knowledge.
The unusual encounter with the Taunia, led PixarBio filed charges in NJ against Taunia Markvicka in spring 2016.
Former Pacira sales person David Kaplan then called PixarBio complaining he had no equity in Pacira and if we gave him equity in PixarBio he would work for PixarBio. Shortly after David Kaplan joined PixarBio he began calling loyal PixarBio employees suggesting they quit PixarBio. David Kaplan then brought on Dr Moed Azzam who worked as an advisor at Pacira and Moed was the caller who made baseless claims to the SEC. Moed Azaam was clueless about PixarBio’s team, business, and operations as he attended two short meetings during his time working for PixarBio
The Four Former Pacira Staff that undermined PixarBio for Pacira are:
1. Moed Azzam- Attended two short PXRB meetings as a PixarBio advisor. Signed as The #1 Plaintiff in the NJ Class Action. Moed Azzam does not legally qualified to be the lead plaintiff
2. David Kaplan- David lied about relationship with Pacira, David is a real fraud who lied almost
every time his lips were moving
3. Taunia Markvicka- A failed sales manager at Pacira Taunia lied about successfully rolling out
Exparel, when in fact she was fired for failing to successfully roll out Exparel. Taunia came to
work for PixarBio lying about still being under contract for Pacira
4. Glenn Reiser – Glenn claimed to be Pacira US Sales manager during interviews, but background
checks found he was local sales rep for Pacira. Glenn had Pacira people lie to confirm his fake background. Glenn brought the rest of the Pacira team to PixarBio
Spring 2016 Claims filed in NJ against Pacira Consultant
It took PixarBio three days to find out PixarBio’s new employee and Pacira’s former National Sales Manager Taunia Markvicka still have a contract to be paid by Pacira over $1M to write reports on PixarBio during 2016.
Taunia left a disturbing voicemail stating that Pacira has secret programs to stop PixarBio, which led to charges being filed in NJ in 2016
The Pacira people kept coming
Next Up Pacira National Sales manager David Kaplan called and complained Pacira refused to give him ANY stock so he wanted to come to work for PixarBio if we paid him stock. David lied to us from the first words spoken to PixarBio. David did indeed have shares of Pacira
David Kaplan brought in Moed Azzam to join the PixarBio advisory team. Kaplan had orders NOT to recommend any advisors to PixarBio that had worked with Pacira. Kaplan bring in Moed Azzam another former Pacira advisor and Moed Azzam called the SEC to try to stop PixarBio, NOT to help PixarBio investors or protect to PixarBio investors but to support David Kaplan attacks and to enrich his own Pacira stock and investor friends. In July 2016, David Kaplan called a PixarBio employee and his spouse at night for 45 minutes, insisting the employee quit PixarBio. Kaplan tried to convince the spouse the husband should quit PixarBio and look for another job. They had 3 children why would they want no income? To quote the employees spouse “Kaplan sounds like he works for Pacira”
How did all four Pacira people arrive at PixarBio in such a short period of time?
This was NO COINCIDENCE
They conducted corporate espionage on behalf of Pacira. David Kaplan was the ring leader.
Exparel is the only non-opiate that is FDA approved for the treatment of post-surgical pain treatment and PixarBio’s NeuroRelease which is still pre-clinical has the pre-clinical science to prove NeuroRelease will make Exparel look sub-optimal in reducing opiate addiction and treating pain.
No surprise, GR was fired by FR. Not a good guy.
